Please complete the CAPTCHA to continue
@mba2016.hbs.edu
✓
1 phone found area 857
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Enke Bashllari, Ph.D. is listed as Health & Bio Investor at Arkitekt Ventures, based in New York, New York, United States. AeroLeads shows a work email signal at mba2016.hbs.edu, phone signal with area code 857, and a matched LinkedIn profile for Enke Bashllari, Ph.D..
Enke Bashllari, Ph.D. previously worked as Founder and Managing Director at Arkitekt Ventures and Investor at Tia. Enke Bashllari, Ph.D. holds Master Of Business Administration - Mba from Harvard Business School.
This section adds company-level context without repeating Enke Bashllari, Ph.D.'s masked contact details.
AeroLeads found 1 current-domain work email signal for Enke Bashllari, Ph.D.. Compare company email patterns before reaching out.
Dr. Enke Bashllari is a neuroscientist and venture investor. She is the Founder and Managing Director of Arkitekt Ventures, a venture capital firm that invests and supports exceptional founders in Health and Bio from the earliest stages of company formation. Dr. Bashllari earned her PhD at Columbia University Medical Center, and her MBA at Harvard Business School.
Listed skills include Start Ups, Neuroscience, Biotechnology, Venture Capital, and 7 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
New York, New York, US
Arkitekt Ventures is an early stage venture firm, with a mission to improve and advance human health. We partner with exceptional founders building the next generation of Health & Bio companies.
San Francisco, California, US
Tia is the modern medical home for women. The company is trailblazing a new paradigm for women’s healthcare that treats women as whole people vs. parts or life stages.
New York, NY, US
Sollis Health offers best-in-class health care via 24/7 medical centers that handle emergencies, everyday checkups, and everything in between for the entire family.
First Close Partners backs venture funds owned by underrepresented managers helping them get to a “first close.” We invest in venture capital firms owned and operated by managers who are people women, people of color, LGBTQIA+, indigenous people, people with disabilities, and members of other groups that have been historically underrepresented, especially.
Boston, MA, US
Nanite is a biotech company developing a new class of polymer nanoparticles for non-viral gene delivery. The company’s AI-driven platform SAYER™, combines high throughput experimental and computational methods to design delivery vehicles with tissue specificity for a variety of genetic medicines.
Los Angeles, California, US
Cofertility is building a human-first fertility ecosystem that empowers everyone to own their own family-building timeline and journey.
New York City, NY, US
Parsley Health is a holistic national medical practice, best described as the future of chronic care management.
San Francisco, California, US
HumanFirst is building the operational infrastructure to support decentralized trials and virtual care at home. Exited as M&A to ICON Plc (NASDAQ: ICLR)
New York, NY, US
Handspring Health provides quality and evidence-based mental healthcare for children.
New York, New York, US
CertifyOS is an API-first, UI agnostic, end-to-end network management platform for provider credentialing, enrollment, monitoring and licensing.
NEW YORK, NY, US
NOVOS is a human longevity company offering science-based and data-driven nutraceutical supplements and tests to address aging.
Boston, Massachusetts, US
The Digital Medicine Society (DiMe) is a professional society serving individuals at the intersection of global healthcare and technology. DiMe supports the development of digital medicine through international interdisciplinary collaboration, research, teaching, and the promotion of best practices.
New York, New York, US
MediVis is bringing augmented reality, computer vision and machine learning to the operating room.
Alachua, Florida, US
Canaery is an early stage biotechnology company engaged in developing a revolutionary ultra wide-band chemical sensor and analytics network.
Hoboken, NJ, US
Culina Health is a personalized, tech-enabled nutrition platform powered by registered dietitians to help you prioritize the way you want to live.
Boston, Massachusetts, US
QSimulate revolutionizes industry R&D with innovative quantum simulations to make meaningful contributions to the drug discovery process.
Boston, MA, US
Connie Health empowers older Americans via their Medicare consumer platform combining a tech-driven recommendation engine with local agents for personalized plan and healthcare navigation.
New York, US
Elaborate is the platform doctors use to send lab results, providing patients with clarity on what the results mean and what to do next.
Austin, Texas, US
Paradromics is bringing to market a high-bandwidth brain machine interface, which will enable patients with debilitating disorders such as ALS or paralysis to reconnect with the outside world.
RAW IS EVERYTHING is a 100% organic, scientifically backed, skincare brand sold at national luxury retailer Bluemercury and clean beauty Follain stores. The company was conceived as part of a project/required curriculum for all first-year Harvard Business School students, and developed into a wellness brand featured in Glamour, New Beauty, Well + Good.
Private global investment vehicle. Direct investments in early-mid stage startups, as well as LP investments in venture, private equity and hedge funds. Active investments in US, Singapore, Europe and New Zealand.
Berkeley, CA, US
Evaluated the commercial viability and scientific merit of the submissions for the $1M Prize. P4L's $1M Therapeutic Prize was established to advance discovery of treatments for ALS, a terminal neurodegenerative disorder.
Auckland, NZ
ICE Angels is Australasia's largest angel investment network. Screening Committee Member for 2013.
New York, New York, US
Executed a genome-wide RNAi screen of 16,000+ genes to identify 245 novel genes with a role in neuronal cell fate. The results, published in top peer-reviewed journals and presented at national and international conferences, help further our understanding of neural fate specification.
Chevy Chase, Maryland, US
Made key discovery that shed light in the current understanding of the pathogenesis of Mucolipidosis IV -a debilitating orphan disease.
Mentor, Ohio, US
Supported product adjustment and new product development of a wide variety of emulsion and solvent based acrylic polymers in response to customer needs.
Quick answers generated from the profile data available on this page.
Enke Bashllari, Ph.D. works for Arkitekt Ventures.
Enke Bashllari, Ph.D. is listed as Health & Bio Investor at Arkitekt Ventures.
AeroLeads has found 1 work email signal at @mba2016.hbs.edu for Enke Bashllari, Ph.D. at Arkitekt Ventures.
AeroLeads has found 1 phone signal(s) with area code 857 for Enke Bashllari, Ph.D. at Arkitekt Ventures.
Enke Bashllari, Ph.D. is based in New York, New York, United States while working with Arkitekt Ventures.
Enke Bashllari, Ph.D. has worked for Arkitekt Ventures, Tia, Sollis Health, First Close Partners, and Nanite.
You can use AeroLeads to view verified contact signals for Enke Bashllari, Ph.D. at Arkitekt Ventures, including work email, phone, and LinkedIn data when available.
Enke Bashllari, Ph.D. holds Master Of Business Administration - Mba from Harvard Business School.
Enke Bashllari, Ph.D. is listed with skills including Start Ups, Neuroscience, Biotechnology, Venture Capital, Investments, Lifesciences, Entrepreneurship, and Genetics.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts